APA Handbook of Psychopharmacology

Part of the landmark APA Handbooks in Psychology^® Series from APA

The APA Handbook of Psychopharmacology provides a comprehensive working knowledge of basic pharmacology and psychopharmacology, examines the utility of pharmacotherapy for addressing different dimensions of human suffering, and highlights the broader professional and social issues surrounding this work in a language that is suitable for a broad readership.

This 33-chapter handbook is designed as a library reference that captures the most current research to date on pharmacotherapy strategies for addressing emotional and behavioral conditions, as an informative guide for educators and students to strengthen their understanding of the scientific and professional issues associated with the field of psychopharmacology, and as an invaluable desk reference for both researchers and practicing clinicians.

Chapters cover fundamental principles of pharmacology and psychopharmacology; psychopharmacology for the treatment of psychological disorders, substance use disorders, and addiction; and issues pertaining to professional training, policy, and industry. Most chapters include a tool kit of resources, providing recommended references that clinicians can use in practice and as educational and teaching tools to stay abreast of the latest developments on the pharmacological treatments for each disorder.

Editorial Board

About the Editor-in-Chief

Contributors

A Note From the Publisher

Introduction

I. Fundamental Principles of Pharmacology and Psychopharmacology

1. A Brief History of Psychopharmacology in the Context of Psychology and Psychiatry
   Robert E. McGrath
2. Basic Information on Psychotropic Drugs, Receptor Systems, and the Brain
   Keith A. Trujillo
3. Basic Psychopharmacology
   Lorenz S. Neuwirth
4. The Role of Animal Laboratory Research in Psychopharmacology
   Susan Schenk, Maree Hunt, Anne Macaskill, and Michaela Pettie
5. The Role of Clinical (Human) Laboratory Research in Psychopharmacology
   Robert Miranda, Jr., Lara A. Ray, and Stephanie S. O'Malley
6. Evidence-Based Pharmacotherapy
   F. Scott Kraly

II. Implementing Psychopharmacology for the Treatment of Psychological Disorders, Substance Use Disorders, and Addiction

Section 1. Pharmacological Treatment of Psychological Disorders

7. Pharmacological Treatment of Depressive Disorders
   Liisa Hantsoo and Sarah Mathews
8. Pharmacological Treatment of Bipolar Disorder
   Joshua D. Rosenblat and Roger S. McIntyre
9. Pharmacological Treatment of Anxiety Disorders
   Allanah J. Wilson and Dan J. Stein
10. Pharmacological Treatment of Schizophrenia and Other Psychotic Disorders
    Mark R. Serper and Karin Tong Wang
11. Pharmacological Treatment of Obsessive-Compulsive Disorder and Related Disorders
    Dean McKay
12. Pharmacological Treatment of Impulse Control Disorders
    Emil F. Coccaro and Jon E. Grant
13. Pharmacological Treatment of Trauma and Stressor-Related Disorders
    Lesia M. Ruglass, Kathryn Z. Smith, Therese K. Killeen, and Denise A. Hien
14. Pharmacological Treatment of Sleep–Wake Disorders
    Emmanuel H. During and Clete A. Kushida
15. Pharmacological Treatment of Eating Disorders
    Robyn Sysko, Tom Hildebrandt, and B. Timothy Walsh
16. Pharmacological Treatment of Attention-Deficit/Hyperactivity Disorder
    Bradley H. Smith, Erin K. Reid, Patrick Sajovec, and Lisa Namerow
17. Pharmacological Treatment of Autism Spectrum Disorder
    Johnny L. Matson and Claire O. Burns
18. Pharmacological Treatment of Neurocognitive Disorders
    Alfredo Carlo Altamura, Matteo Lazzaretti, Andrea Arighi, Alessandro Pigoni, Elio Scarpini, and Paolo Brambilla
19. Pharmacological Treatment of Pain and Pain-Related Disorders
    Julie R. Price, Micah J. Price, and Amie Hall
20. Pharmacological Treatment of Borderline Personality Disorder
    Amit Bhaduri, Katherine Thompson, and Andrew Chanen

Section 2. Pharmacological Treatment of Substance Use Disorders and Addiction

21. General Introduction: Issues and Perspective on Medication Assisted Treatment
    Kyle K. Kampman
22. Pharmacological Treatment of Alcohol Use Disorder
    Barbara J. Mason
23. Pharmacological Treatment of Cannabis Use Disorder
    Jan Copeland
24. Pharmacological Treatment of Psychostimulant Use Disorders
    Joy M. Schmitz, Margaret C. Wardle, Michael F. Weaver, Angela M. Heads, Jin H. Yoon, and Scott D. Lane
25. Pharmacological Treatment of Opioid Use Disorders
    Hilary S. Connery and R. Kathryn McHugh
26. Pharmacological Treatment of Sedative and Anxiolytic Use Disorders
    Angela M. Heads, Michael F. Weaver, and Paula Lopez-Gamundi
27. Pharmacological Treatment of Tobacco Use Disorder
    David J. Drobes
28. Pharmacological Treatment of Behavioral Addictions
    Meredith K. Ginley, Kristyn Zajac, Carla J. Rash, and Nancy M. Petry

III. Psychopharmacology in Context: Issues Pertaining to Professional Training, Policy, and Industry

29. Professional Psychology in the Context of Psychopharmacology: Ethical Issues, Education, and Training
    Lynette A. Pujol and Bret A. Moore
30. Psychologists and Integrated Behavioral Health Care Within the Framework of Psychopharmacology
    Ana J. Bridges
31. The Role of the Pharmaceutical Industry in the Treatment of Mental Health Disorders
    Bethea A. Kleykamp and Jack E. Henningfield
32. Nonpharmacological Neurotherapeutics: Principles and Methods of Brain Stimulation Therapy
    Marc L. Copersino
33. Future Directions in Theory, Research, Practice, and Policy
    Patrick H. DeLeon, Fernanda P. De Oliveira, and Antonio E. Puente

Index

Suzette M. Evans, PhD, is a psychologist trained in biopsychology at The University of Chicago and in behavioral pharmacology at the Johns Hopkins University School of Medicine.

Dr. Evans has more than 100 publications and 30 years of research experience that span preclinical research with laboratory animals, human laboratory research, and clinical treatment research in substance abuse. She is currently professor of clinical neuroscience and research scientist in the Department of Psychiatry at Columbia University Medical Center and the New York State Psychiatric Institute.

Dr. Evans is a longtime member of APA and served as president of Division 28 (Society for Psychopharmacology and Substance Use) in 2007. She also is a past editor of the journal Experimental and Clinical Psychopharmacology.

"This comprehensive, 33-chapter desk reference, published by the highly reputable APA, captures the current research for emotional and behavioral conditions…. Highly recommended."
—Choice